Prevalence Rates of Arterial Hypertension According to the Threshold Criteria of 140/90 or 130/80 mmHg and Associated Cardiometabolic and Renal Factors: SIMETAP-HTN Study.

Autor: Pallarés-Carratalá V; Health Surveillance Unit, Mutual Insurance Union, 12004 Castellon, Spain.; Department of Medicine, Jaume I University, 12006 Castellon, Spain., Ruiz-García A; Lipids and Cardiovascular Prevention Unit, Pinto University Health Centre, Pinto, 28320 Madrid, Spain.; Department of Medicine, European University of Madrid, Villaviciosa de Odon, 28670 Madrid, Spain., Serrano-Cumplido A; Family and Community Medicine, Getxo, 48993 Bizkaia, Spain., Arranz-Martínez E; San Blas Health Centre, Parla, 28981 Madrid, Spain., Divisón-Garrote JA; Casas Ibáñez Health Center, 02200 Albacete, Spain., Moyá-Amengual A; Santa Catalina Health Centre, 07001 Palma, Spain., Escobar-Cervantes C; La Paz University Hospital, 28046 Madrid, Spain., Barrios V; Ramon y Cajal University Hospital, 28034 Madrid, Spain.; Department of Medicine, Alcala University, 28801 Madrid, Spain.
Jazyk: angličtina
Zdroj: Medicina (Kaunas, Lithuania) [Medicina (Kaunas)] 2023 Oct 17; Vol. 59 (10). Date of Electronic Publication: 2023 Oct 17.
DOI: 10.3390/medicina59101846
Abstrakt: Background and objectives : Arterial hypertension (HTN) is the leading preventable cause of atherosclerotic cardiovascular diseases (ASCVD) and death from all causes. This study aimed to determine the prevalence rates of HTN diagnosed according to the threshold diagnostic criteria 130/80 mmHg and 140/90 mmHg, to compare blood pressure (BP) control, and to evaluate their associations with cardiovascular diseases and cardiometabolic and renal risk factors. Materials and Methods : This was a cross-sectional observational study conducted in primary care with a population-based random sample: 6588 people aged 18.0-102.8 years. Crude and adjusted prevalence rates of HTN were calculated. BP control was compared in HTN patients with and without ASCVD or chronic kidney disease (CKD). Their associations with cardiovascular diseases and cardiometabolic and renal factors were assessed using bivariate and multivariate analysis. Results : Adjusted prevalence rates of HTN diagnosed according to 140/90 and 130/90 criteria were 30.9% (32.9% male; 29.7% female) and 54.9% (63.2% male; 49.3% female), respectively. BP < 130/80 mmHg was achieved in 60.5% of HTN patients without ASCVD or CKD according to 140/90 criterion, and 65.5% according to 130/80 criterion. This BP-control was achieved in 70% of HTN patients with ASCVD and 71% with CKD, according to both criteria. Coronary heart disease (CHD), heart failure, atrial fibrillation, stroke, diabetes, prediabetes, low glomerular filtration rate (eGFR), hyperuricemia, hypercholesterolemia, obesity, overweight, and increased waist-to-height ratio were independently associated with HTN according to both criteria. Conclusions : Almost a third of the adult population has HTN according to the 140/90 criterion, and more than half according to the 130/90 criterion, with a higher prevalence in men. The main clinical conditions associated with HTN were heart failure, diabetes, CHD, low eGFR, and obesity.
Databáze: MEDLINE